Author

Michał Królik

Observed names: Krolik, Michal, Michal Krolik

Institution: Kantonsspital St. Gallen

Observed institutions: University of Basel, Kantonsspital St. Gallen, Fraunhofer Institute for Molecular Biology and Applied Ecology, RWTH Aachen University

ORCID: 0000-0003-3196-143X

Observed ORCID: 0000-0003-3196-143X

OpenAlex ID: A5103104931

Antibodies as biomarker candidates for response and survival to checkpoint inhibitors in melanoma patients

2019 · Mirjam Fässler, Stefan Diem, et al. · Journal for ImmunoTherapy of Cancer · 80

Characterization of a novel inhibitory human monoclonal antibody directed against Plasmodium falciparum Apical Membrane Antigen 1

2016 · Dominika J. Maskus, Michał Królik, et al. · Scientific Reports · 32

pH-dependent nano-capturing of tartaric acid using dendrimers

2013 · Oana G. Schramm, Xaviera López-Cortés, et al. · Soft Matter · 8

Heterologous Prime Boost Vaccination Induces Protective Melanoma-Specific CD8+ T Cell Responses

2020 · Sandra S. Ring, Michał Królik, et al. · Molecular Therapy — Oncolytics · 6

Recombinant lymphocytic choriomeningitis virus-based vaccine vector protects type I interferon receptor deficient mice from viral challenge

2021 · Michal Krolik, Lucia Csepregi, et al. · Vaccine · 4

Viral infection overcomes ineffectiveness of anti-tumoral CD8+ T cell mediated cytotoxicity

2019 · Fan Zhou, Justa Kardash, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1

Works count: 11

Citation count: 131

H-index: 4

I10-index: 2